WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Website Development Thursday, October 21, 2021 
Add Press Release News | News Feeds Feeds | Email This News Email


AnchorDx Develops New Liquid Biopsy Diagnostic Model for Early Detection of Breast Cancer
Tuesday, September 21, 2021

GUANGZHOU, China, Sept. 13, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, together with renowned experts from a top-tier hospital in China, jointly published an article entitled "Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis" in well-known journal, npj Breast Cancer. The new diagnostic model is based on circulating cell-free DNA-based (cfDNA) methylation patterns. It can serve as a reliable approach for the early diagnosis of breast cancer and is expected to compensate for the deficiency of mammography.

Mammography-based screening (an X-ray picture of the breast) has contributed to a reduction in breast cancer mortality. However, younger women have lower mammographic sensitivity, especially Asian women, who tend to have a higher density of breast tissue. Therefore, novel and accurate detection methods in early breast cancer diagnosis are needed.

In order to compensate for the defects of mammography, AnchorDx conducted cfDNA methylation profiling to develop and validate a liquid biopsy-based breast cancer diagnostic test. They derived a specific panel of markers based on computational analysis of the DNA methylation profiles from The Cancer Genome Atlas (TCGA). Through training (n=160) and validation set (n=69), they developed a diagnostic prediction model with 26 markers. The model yielded a sensitivity of 94.79% and a specificity of 98.70% for differentiating malignant disease from normal lesions (AUROC = 0.9815, and AUPRC = 0.9800), and had better diagnostic power than that of using mammography (AUROC = 0.9315, and AUPRC = 0.9490). As a result, the cfDNA methylation model for breast cancer diagnosis showed increased performance over mammography.

As a leading biotechnology company developing high-throughput methylation sequencing of ctDNA for early cancer diagnosis, AnchorDx will collect more case and testing data for validating the model. The hope is this model will help lower breast cancer risk, especially for women who are at high risk in China in the near future.

About AnchorDx

Founded in 2015, AnchorDx is a world-leading developer of cancer screening and early detection solutions based on methylation NGS technology. AnchorDx strives to revolutionize single/multi/pan-cancer early screening, detection technologies, and products. The current product pipeline encompasses more than 70% of high-incidence cancers. In addition, AnchorDx has a proprietary big data and artificial intelligence platform designed for early lung cancer screening, diagnosis, and treatment.

For more information, please contact contact-us@anchordx.com .

View original content to download multimedia:https://www.prnewswire.com/news-releases/anchordx-develops-new-liquid-biopsy-diagnostic-model-for-early-detection-of-breast-cancer-301375259.html

SOURCE AnchorDx



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav 2020's Promob Software Solutions Announces Acquistion of Focco Management Solutions | Oct 21, 2021
Nav TSRgrow Expands GROWHub(TM), A Solution for Smarter Growing | Oct 21, 2021
Nav Blackbird wins Best Mobile Video Solution at 2021 Streaming Media European Readers' Choice Awards | Oct 21, 2021
Nav Project Venkman launches to transform enterprise loyalty programs through blockchain, NFT technology | Oct 21, 2021
Nav IBM Commits to Skill 30 Million People Globally by 2030 | Oct 21, 2021
Nav Tripadvisor to Host Third Quarter 2021 Conference Call on November 9, 2021 | Oct 21, 2021
Nav Daiya Launches New Foodservice Website As Demand for Plant-Based Options Soars | Oct 21, 2021
Nav PlayDapp Leads the way in Play-to-Earn games Launching P2E Server for 'Along with the Gods' with pre-registration | Oct 21, 2021
Nav TransPerfect Technology Platform Selected By 2-1-1 Arizona To Automate Launch And Maintenance Of Spanish Website | Oct 21, 2021
Nav Audio Eyewear Gets A Much-Needed Makeover With New Soundcore Frames | Oct 21, 2021
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News